Erleada, also known by its generic name apalutamide, is a medication used in the treatment of prostate cancer. It belongs to a class of drugs known as antiandrogens, which work by blocking the action of androgens, the male hormones that can fuel the growth of prostate cancer cells.

Erleada is typically prescribed for patients with non-metastatic castration-resistant prostate cancer, a form of the disease that has not spread to other parts of the body but is no longer responding to hormone therapy. By inhibiting the activity of androgens, Erleada can help slow the progression of the cancer and improve overall survival rates.

As with any medication, Erleada may cause side effects in some patients. Common side effects include fatigue, rash, diarrhea, and high blood pressure. It is important to discuss any concerns or side effects with your healthcare provider to determine the best course of action.

It is crucial to take Erleada exactly as prescribed by your healthcare provider. Missing doses or stopping the medication prematurely can reduce its effectiveness and may not provide the desired outcome in the treatment of prostate cancer.

If you have been prescribed Erleada, it is important to follow up regularly with your healthcare provider to monitor your progress and adjust your treatment plan as needed. Your healthcare team is here to support you every step of the way in your journey to manage and treat prostate cancer.